eSignature

First-hand field checks suggest Docusign Inc (NASDAQ: DOCU) is performing better than expected amid the COVID-19 pandemic, according to Wedbush. The Docusign Analyst: Daniel Ives maintains an Outperform rating on Docusign's stock with a price target lifted from $165 to $240. The Docusign Thesis...

Docusign Inc (NASDAQ: DOCU) reported a first-quarter top-and-bottom-line beat Thursday, reinforcing the company's long-term prospects, according to Citi. The Analyst Citi's Walter Pritchard maintains a Buy rating on DocuSign with a price target lifted from $59 to $70. The Thesis...